Pharmacological manipulation of IL-6 secretion or the IL-6 trans-signaling pathway may offer us novel possibilities for the therapy of autoimmune diseases, infections, as well as new generation vaccine design (Garbers et al. 2018). This evidence concerns the gene IL6 and autoimmune disease.